ASN's Mission

To create a world without kidney diseases, the ASN Alliance for Kidney Health elevates care by educating and informing, driving breakthroughs and innovation, and advocating for policies that create transformative changes in kidney medicine throughout the world.

learn more

Contact ASN

1401 H St, NW, Ste 900, Washington, DC 20005


The Latest on X

Kidney Week

Educational Symposium

Hyperkalemia in Diabetes and Heart Failure: Optimizing Management to Mitigate Risk

November 03, 2023 | 12:45 PM - 01:45 PM

Location: Grand Ballroom Salon I, Level 5, Philadelphia Marriott Downtown

Session Description

Hyperkalemia is a common problem in patients with diabetic kidney disease (DKD) and heart failure, is associated with increased cardiovascular morbidity and mortality, and is burdensome to health care systems. Patients with DKD often have inherent hyperkalemic tendencies. Optimization of medications that slow disease progression, including established and next-generation renin-angiotensin-system (RAS) blockers and mineralocorticoid receptor antagonists (MRAs), is limited by the development of hyperkalemia. Yet evidence suggests that hyperkalemia-driven undertreatment with these agents is associated with adverse clinical outcomes.

This symposium reviews causes and effects of hyperkalemia in patients with DKD and heart failure and discusses management strategies that aid in the optimization of medical therapy for these conditions.

Support is provided by an educational grant from AstraZeneca.

Learning Objective(s)

  • Identify natural and iatrogenic factors that cause hyperkalemia in patients with DKD and heart failure
  • Describe strategies to mitigate hyperkalemia in patients with DKD and heart failure

Learning Pathway(s)

  • CKD Non-Dialysis
  • Diabetic Kidney Disease